UNSPSC 51351600: Estrogen, progestin, or internal contraceptive estrenes

Estrogens, progestins, or internal contraceptives made from unsaturated derivatives of the estranes with methyl groups at carbon-13, with no carbon at carbon-10, and with no more than one carbon at carbon-17.

UNSPSC 51351600 Estrogen, progestin, or internal contraceptive estrenes is a Class code under which state and local governments procure pharmaceutical products, specifically generic multi-source contraceptive medications and related OTC items through cooperative purchasing agreements. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, solicits manufacturers and suppliers to provide comprehensive pharmaceutical products with specified National Drug Codes (NDC), SKUs, UPCs, and packaging configurations. Vendors must certify compliance with current Good Manufacturing Practices (cGMP) and the Drug Supply Chain Security Act (DSCSA), maintain contractual relationships with at least two of three authorized wholesalers (AmerisourceBergen Drug Corporation / Cencora, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC) with chargeback systems in place, and carry comprehensive insurance including commercial general liability of $5 million per occurrence, network security and privacy liability of $2 million, and professional liability of $2 million. All products must comply with FDA requirements and possess expiration dates of at least one year from manufacture with a minimum six-month shelf life. Pricing is evaluated on fixed pricing for the contract term (10 percent weight), compliance with administrative fee data format requirements (5 percent), EDI capability (5 percent), agreement to a 3 percent administrative fee (5 percent), and price competitiveness (75 percent), with vendors required to submit pricing in flat price, net price formats (NF30, NF60, NF90), or WAC-minus structures.

MMCAP issued a Request for Proposal (S1070000015802) on January 20, 2026, with proposals due March 26, 2026, to establish multiple contracts for generic multi-source pharmaceuticals and OTC products to be distributed across participating state and local government facilities, including Oregon. The procurement covers Minnesota and participating multistate members through a cooperative purchasing vehicle, with awarded vendors provided to authorized wholesalers by May 15, 2026 and resulting agreements effective July 1, 2026. The contract term is two years for new responders with optional extensions at MMCAP's discretion, while incumbent responder amendments align with existing agreement expiration dates through June 30, 2028. Submissions must be made through the ePro procurement system using Google Chrome, with pricing and product information submitted in designated Excel spreadsheet format converted to CSV, accompanied by supporting documentation emailed to MMCAP_Infuse.RFP@state.mn.us. Performance penalties ranging from $200 to $1,500 per violation apply for late reporting, missed onboarding timelines, or improper class-of-trade denials. MMCAP reserves the right to make sole awards, dual awards, or multi-awards based on therapeutic considerations, product availability, patient safety, and member-specific needs.